rs2229500

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_003243.5(TGFBR3):​c.1341C>T​(p.Ser447=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0183 in 1,614,078 control chromosomes in the GnomAD database, including 310 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.016 ( 30 hom., cov: 32)
Exomes 𝑓: 0.019 ( 280 hom. )

Consequence

TGFBR3
NM_003243.5 synonymous

Scores

2

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 0.205
Variant links:
Genes affected
TGFBR3 (HGNC:11774): (transforming growth factor beta receptor 3) This locus encodes the transforming growth factor (TGF)-beta type III receptor. The encoded receptor is a membrane proteoglycan that often functions as a co-receptor with other TGF-beta receptor superfamily members. Ectodomain shedding produces soluble TGFBR3, which may inhibit TGFB signaling. Decreased expression of this receptor has been observed in various cancers. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene.[provided by RefSeq, Sep 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 1-91719965-G-A is Benign according to our data. Variant chr1-91719965-G-A is described in ClinVar as [Benign]. Clinvar id is 3055456.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.205 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0157 (2390/152206) while in subpopulation NFE AF= 0.0207 (1409/68020). AF 95% confidence interval is 0.0198. There are 30 homozygotes in gnomad4. There are 1243 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2390 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TGFBR3NM_003243.5 linkuse as main transcriptc.1341C>T p.Ser447= synonymous_variant 9/17 ENST00000212355.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TGFBR3ENST00000212355.9 linkuse as main transcriptc.1341C>T p.Ser447= synonymous_variant 9/171 NM_003243.5 P3Q03167-1

Frequencies

GnomAD3 genomes
AF:
0.0157
AC:
2389
AN:
152088
Hom.:
30
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00427
Gnomad AMI
AF:
0.0165
Gnomad AMR
AF:
0.0202
Gnomad ASJ
AF:
0.00663
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00416
Gnomad FIN
AF:
0.0376
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0207
Gnomad OTH
AF:
0.0158
GnomAD3 exomes
AF:
0.0154
AC:
3871
AN:
251254
Hom.:
46
AF XY:
0.0155
AC XY:
2104
AN XY:
135778
show subpopulations
Gnomad AFR exome
AF:
0.00394
Gnomad AMR exome
AF:
0.0107
Gnomad ASJ exome
AF:
0.00764
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00451
Gnomad FIN exome
AF:
0.0397
Gnomad NFE exome
AF:
0.0197
Gnomad OTH exome
AF:
0.0214
GnomAD4 exome
AF:
0.0186
AC:
27169
AN:
1461872
Hom.:
280
Cov.:
32
AF XY:
0.0182
AC XY:
13241
AN XY:
727234
show subpopulations
Gnomad4 AFR exome
AF:
0.00266
Gnomad4 AMR exome
AF:
0.0117
Gnomad4 ASJ exome
AF:
0.00754
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00492
Gnomad4 FIN exome
AF:
0.0403
Gnomad4 NFE exome
AF:
0.0205
Gnomad4 OTH exome
AF:
0.0157
GnomAD4 genome
AF:
0.0157
AC:
2390
AN:
152206
Hom.:
30
Cov.:
32
AF XY:
0.0167
AC XY:
1243
AN XY:
74408
show subpopulations
Gnomad4 AFR
AF:
0.00429
Gnomad4 AMR
AF:
0.0201
Gnomad4 ASJ
AF:
0.00663
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00437
Gnomad4 FIN
AF:
0.0376
Gnomad4 NFE
AF:
0.0207
Gnomad4 OTH
AF:
0.0156
Alfa
AF:
0.0131
Hom.:
15
Bravo
AF:
0.0137
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.0210
EpiControl
AF:
0.0209

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

TGFBR3-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 21, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
8.7
DANN
Benign
0.56
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2229500; hg19: chr1-92185522; API